| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |